The authors concluded that cooperative ASXL1 mutations were frequent (57%) and independently predictive of a shortened overall survival in in CSF3R-mutated CNL patients, consistent with their negative prognostic role in other myeloid malignancies. The gene discussed is CSF3R; the disease is chronic neutrophilic leukemia.